Historical shareholding details of iShares Nasdaq US Biotechnology ETF holdings in Acelyrin Inc (SLRN)

Monthly changes of iShares Nasdaq US Biotechnology ETF shareholding in Acelyrin Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Nasdaq Us Biotechnology Etf 48,947 0.05%
Feb 26, 2025 Ishares Nasdaq Us Biotechnology Etf 48,947 0.05%
Jan 31, 2025 Ishares Nasdaq Us Biotechnology Etf 47,507 0.05%
Jan 29, 2025 Ishares Nasdaq Us Biotechnology Etf 47,507 0.05%
Dec 31, 2024 Ishares Nasdaq Us Biotechnology Etf 47,187 0.05%
Dec 30, 2024 Ishares Nasdaq Us Biotechnology Etf 47,187 0.05%
Dec 27, 2024 Ishares Nasdaq Us Biotechnology Etf 47,187 0.05%
Nov 30, 2024 Ishares Nasdaq Us Biotechnology Etf 55,465 0.06%
Nov 27, 2024 Ishares Nasdaq Us Biotechnology Etf 55,465 0.06%
Oct 31, 2024 Ishares Nasdaq Us Biotechnology Etf 58,364 0.06%
Oct 30, 2024 Ishares Nasdaq Us Biotechnology Etf 58,364 0.06%
Sep 30, 2024 Ishares Nasdaq Us Biotechnology Etf 58,919 0.06%
Sep 27, 2024 Ishares Nasdaq Us Biotechnology Etf 58,919 0.06%
Sep 25, 2024 Ishares Nasdaq Us Biotechnology Etf 58,734 0.06%
Aug 30, 2024 Ishares Nasdaq Us Biotechnology Etf 57,624 0.06%
Aug 29, 2024 Ishares Nasdaq Us Biotechnology Etf 57,624 0.06%
Aug 28, 2024 Ishares Nasdaq Us Biotechnology Etf 57,624 0.06%
Jul 31, 2024 Ishares Nasdaq Us Biotechnology Etf 58,923 0.06%
Jul 29, 2024 Ishares Nasdaq Us Biotechnology Etf 58,923 0.06%
Jun 28, 2024 Ishares Nasdaq Us Biotechnology Etf 58,922 0.06%
Jun 25, 2024 Ishares Nasdaq Us Biotechnology Etf 58,922 0.06%
May 29, 2024 Ishares Nasdaq Us Biotechnology Etf 50,785 0.05%
Apr 26, 2024 Ishares Nasdaq Us Biotechnology Etf 50,785 0.05%
Mar 28, 2024 Ishares Nasdaq Us Biotechnology Etf 51,613 0.05%
Mar 27, 2024 Ishares Nasdaq Us Biotechnology Etf 51,613 0.05%
Feb 29, 2024 Ishares Nasdaq Us Biotechnology Etf 49,142 0.05%
Feb 28, 2024 Ishares Nasdaq Us Biotechnology Etf 48,327 0.05%
Jan 31, 2024 Ishares Nasdaq Us Biotechnology Etf 48,489 0.05%
Dec 27, 2023 Ishares Nasdaq Us Biotechnology Etf 47,835 0.05%

View all ownership details of Acelyrin Inc